2022-2026 POC Hematology and Flow Cytometry Testing Market: Reagent and Instrument Supplier Shares, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Landscape, Opportunities for Suppliers

2022-2026 POC Hematology and Flow Cytometry Testing Market: Reagent and Instrument Supplier Shares, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Landscape, Opportunities for Suppliers

LeadingMarketResearch.com's new report provides comprehensive analysis of the POC hematology and flow cytometry markets, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation

- Review of POC hematology and flow cytometry market segments, including their dynamics, trends, structure, size, growth and major suppliers.

- Five-year test volume and reagent sales forecasts for hematology and flow cytometry procedures by market segment:,
Physician Offices/Group Practices
Emergency Rooms
Operating/Recovery Suites
ICUs/CCUs
Cancer Clinics
Ambulatory Care Centers
Surgery Centers
Nursing Homes
Birth Centers

Sales and Market Share Analysis

- Sales and market shares of major reagent and instrument suppliers.

Routine and Special Hematology Tests

CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual), Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils and others.

Flow Cytometry Tests

Cell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/RNA Analysis, Cell Culturing.

Technology Review

- Emerging technologies and their applications for POC testing.
Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.

Strategic Recommendations

- Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years.
Design criteria for POC testing products.
Alternative business expansion strategies.
Potential market entry barriers and risks.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.

The companies analyzed in the report include:

Abbott
Accriva
Agilent Technologies
Axis-Shield
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data
bioMerieux
Bio-Rad
Cepheid
Chrono-Log
Corgenix
Decode Genetics
Diagnostica Stago
Diamedix
DiaSorin
Eiken Chemical
EKF Diagnostics
Fujirebio
Grifols
Helena Laboratories
Hologic
Horiba
Instrumentation Laboratory/Werfen
Kyowa Medex
Leica Biosystems
Lonza
Nihon Kohden
Ortho-Clinical Diagnostics
Polymedco
Qiagen
Roche
SDIX
Sekisui Diagnostics
Sequenom
Siemens Healthineers
Sienco
Sysmex
Takara Bio
Thermo Fisher
Tosoh
Wako

Methodology

This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.

Contains279 pages and 58 tables

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.